M&T Bank Corp Sells 3,538 Shares of HealthEquity, Inc. (NASDAQ:HQY)

M&T Bank Corp cut its stake in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 7.2% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 45,909 shares of the company's stock after selling 3,538 shares during the quarter. M&T Bank Corp owned about 0.05% of HealthEquity worth $4,405,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in HQY. Smartleaf Asset Management LLC lifted its stake in HealthEquity by 34.3% in the 4th quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock worth $37,000 after purchasing an additional 98 shares in the last quarter. Louisiana State Employees Retirement System boosted its stake in HealthEquity by 0.4% during the fourth quarter. Louisiana State Employees Retirement System now owns 24,200 shares of the company's stock valued at $2,322,000 after buying an additional 100 shares during the period. Oregon Public Employees Retirement Fund grew its position in HealthEquity by 0.6% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 17,776 shares of the company's stock worth $1,706,000 after buying an additional 100 shares in the last quarter. State of Michigan Retirement System increased its stake in HealthEquity by 0.5% in the 4th quarter. State of Michigan Retirement System now owns 20,722 shares of the company's stock worth $1,988,000 after acquiring an additional 100 shares during the last quarter. Finally, Raymond James Trust N.A. raised its holdings in shares of HealthEquity by 4.8% in the 3rd quarter. Raymond James Trust N.A. now owns 2,905 shares of the company's stock valued at $238,000 after acquiring an additional 132 shares in the last quarter. 99.55% of the stock is currently owned by institutional investors.

Remove Ads

Analyst Ratings Changes

Several research analysts recently weighed in on the stock. JMP Securities upped their price objective on shares of HealthEquity from $105.00 to $107.00 and gave the stock a "market outperform" rating in a research report on Tuesday, December 10th. Mizuho assumed coverage on HealthEquity in a research report on Wednesday, December 4th. They set an "outperform" rating and a $126.00 price target on the stock. Royal Bank of Canada lifted their price target on HealthEquity from $100.00 to $105.00 and gave the stock an "outperform" rating in a research note on Tuesday, December 10th. Raymond James increased their price objective on HealthEquity from $105.00 to $120.00 and gave the company an "outperform" rating in a research report on Tuesday, February 25th. Finally, Wells Fargo & Company boosted their target price on HealthEquity from $110.00 to $125.00 and gave the stock an "overweight" rating in a research report on Wednesday, February 26th. One equities research analyst has rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $113.54.

HealthEquity Trading Up 1.3 %

NASDAQ:HQY traded up $1.26 during midday trading on Tuesday, reaching $95.74. 888,641 shares of the stock traded hands, compared to its average volume of 649,958. The stock has a market capitalization of $8.30 billion, a P/E ratio of 87.83, a PEG ratio of 1.60 and a beta of 0.62. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. The company has a fifty day moving average of $105.75 and a 200 day moving average of $94.80. HealthEquity, Inc. has a 12 month low of $65.01 and a 12 month high of $115.59.

HealthEquity (NASDAQ:HQY - Get Free Report) last issued its quarterly earnings data on Monday, December 9th. The company reported $0.59 EPS for the quarter, missing the consensus estimate of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same quarter in the prior year, the company earned $0.40 EPS. On average, research analysts predict that HealthEquity, Inc. will post 2.32 EPS for the current year.

Insider Activity at HealthEquity

In other HealthEquity news, Director Stuart B. Parker sold 25,000 shares of HealthEquity stock in a transaction that occurred on Thursday, December 12th. The stock was sold at an average price of $96.72, for a total transaction of $2,418,000.00. Following the sale, the director now directly owns 19,061 shares of the company's stock, valued at approximately $1,843,579.92. The trade was a 56.74 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Robert W. Selander sold 5,750 shares of the stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $111.29, for a total value of $639,917.50. Following the completion of the transaction, the director now directly owns 78,219 shares of the company's stock, valued at $8,704,992.51. This represents a 6.85 % decrease in their position. The disclosure for this sale can be found here. 2.20% of the stock is owned by corporate insiders.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.